Skip to main content

Table 1 Discrepancies between reported and documented medications prescribed for the management of liver-related complications

From: Prevalence of medication discrepancies in patients with cirrhosis: a pilot study

Number of liver medicationsa Patient reported but not documented in medical record Documented in medical record but not reported by patient Concordant medications Proportion (%) discordant records within drug-disease category
Diuretics n = 16 1 2 13 18.8 %
Propranolol n = 9 0 0 9 0.0 %
Cholecalciferol n = 8 4 0 4 50.0 %
PPIs n = 7 2 1 4 42.9 %
Thiamine n = 6 1 0 5 16.7 %
Lactulose n = 5 0 3 2 60.0 %
Antivirals n = 4 0 0 4 0.0 %
Other n = 9b 3 1 5 44.4 %
  1. aExcluding 6 liver medications which were only documented in ELMs (n = 1 for thiamine, rifaximin, PPI, lactulose, cholecalciferol, spironolactone)
  2. bRifaximin, spontaneous bacterial peritonitis prophylaxis, ursodeoxecholic acid, other vitamins and protein supplements prescribed for complications of cirrhosis